Blood-Brain Barrier (BBB) Penetrance
The Blood-Brain Barrier (BBB) is like a **military checkpoint** between your bloodstream and your brain. It's made of tightly packed cells with no gaps — designed to keep toxins out. But it also keeps...
Explainers
Plain-English explanations of MEF2C research terms, concepts, and scientific mechanisms.
MicroRNA (in the context of MHS RNA therapeutics)
MicroRNAs are tiny RNA molecules (about 22 nucleotides long) that regulate gene expression after transcription. They can bind to mRNA molecules and either block them from being translated into protein...
Drug Pipeline (in pharma context)
**What it means:** A "drug pipeline" is the entire journey a drug takes from the lab bench to the pharmacy shelf. Think of it as a factory assembly line: 1. **Discovery** → finding compounds that affe...
Drug Development Milestones (quick reference)
...
Drug Candidate vs. Therapeutic Candidate
...
First-in-Human (FIH) Trial
**What it means:** This is the **very first time a drug is given to people** — never humans before, only animals (and cell cultures). It's essentially Phase 1a. The goals are: 1. **Safety** — does the...
Behavioral Brain Research Foundation (BDRF)
**What it means:** The BDRF is a **private foundation** that funds neuroscience research. Their "Distinguished Investigative Grant" is a significant award given to researchers who have demonstrated ex...
Inpart (Industry Partnering Platform)
**What it means:** Inpart is a **global scientific partnering platform** used by 90% of the world's top 50 pharmaceutical companies. Think of it as LinkedIn for drug development — it tracks which acad...
Theripio Innovations (the startup)
**What it means:** Theripio Innovations is the **startup company** founded by Dr. Christopher Cowan at MUSC to commercialize the MEF2C RNA therapeutic platform. In drug development, when academic rese...
Clinical Readiness Study (vs. Clinical Trial)
**What it means:** A **"clinical readiness study"** is different from a full clinical trial. It's the work done *before* a trial to make sure the trial can actually happen. This includes: - **Patient ...
MicroRNA Therapeutic Advantage (why MUSC chose RNA over gene therapy)
**What it means:** The MUSC team evaluated multiple approaches (gene therapy, micro-RNA therapeutics) and chose the RNA-based approach because it "offered several advantages." These likely include: - ...
Oncology / Solid Tumor (in CDK2 inhibitor context)
**What it means:** Oncology is the branch of medicine that deals with cancer. "Solid tumors" are cancers that form actual lumps or masses (as opposed to blood cancers like leukemia). Breast, ovarian, ...
Preclinical Update (in gene therapy context)
**What it means:** "Preclinical" means research done **before human trials begin** — in cell cultures (in vitro) and animal models (in vivo). A "preclinical update" means the researchers have complete...
Patient-Derived (in cell biology context)
**What it means:** "Patient-derived" means cells, tissues, or samples that were taken **directly from a patient** (usually via biopsy or blood draw) and used in research. This is different from cancer...
ctDNA (Circulating Tumor DNA)
**What it means:** Tumors shed tiny fragments of their DNA into the bloodstream — this is "circulating tumor DNA." By measuring ctDNA levels in a blood draw (a "liquid biopsy"), doctors can track canc...
Synthetic Lethality (cancer terminology that appears in CDK2 context)
**What it means:** Synthetic lethality occurs when a cell survives with just ONE gene broken but dies if a SECOND gene is also broken. Cancer drugs exploit this by killing cancer cells (which already ...
Natural History Study
**What it means:** A natural history study systematically tracks a disease **without giving any treatment**. It's like creating a detailed map of a territory before you try to change it — you need to ...
RNA Therapeutics
**What it means:** RNA is the molecular "messenger" that carries instructions from DNA to the protein-making machinery of the cell. RNA therapeutics work by modifying this messaging process. For MHS, ...
PFS (Progression-Free Survival)
**What it means:** PFS is a common clinical trial metric. It measures **how long patients live without their disease getting worse** — specifically, without the cancer growing or spreading. It's measu...
Phase 1a/b Clinical Trial
**What the phases mean:** - **Phase 1a:** First-in-human testing. The primary goal is **safety** — "Is this drug safe in humans at all?" A small group of patients receives escalating doses to find the...
PROTAC (Proteolysis-Targeting Chimaera)
**What it means:** PROTACs are a **completely different class of drug** from traditional inhibitors. Traditional inhibitors work like a cork in a bottle — they block a protein's function while the dru...
Blood-Brain Barrier (BBB)
**What it means:** The BBB is an ultra-tight layer of cells lining the brain's blood vessels. Think of it like a **super-filter** or a nightclub with an extremely strict bouncer — it lets nutrients an...
De Novo Mutation
**What it means:** A de novo (Latin for "from new") mutation is a genetic change that occurs **for the first time** in a person — it wasn't inherited from either parent. The parents' DNA is normal; th...